MC
BSX icon

Moors & Cabot’s Boston Scientific BSX Stock Holding History

Moors & Cabot’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-400
Closed -$1.84K – 884
2024
Q4 		$1.84K Buy
+400
New +$35.2K ﹤0.01% 882

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moors & Cabot's BSX Position: Q1 2026 in Review

Moors & Cabot increased its Boston Scientific (BSX) stake by 5.9% in Q1 2026, buying an estimated $126K and bringing the position to 28,039 shares worth $1.76M. The position accounts for 0.08% of the portfolio, ranked #235.

Moors & Cabot first reported a position in BSX in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.82M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Moors & Cabot held 28,039 shares of Boston Scientific worth $1.76M as of Q1 2026.
  • Moors & Cabot bought 1,572 Boston Scientific shares in Q1 2026, an estimated $126K.
  • Boston Scientific made up 0.08% of Moors & Cabot's portfolio in Q1 2026, its #235 holding.
  • Moors & Cabot first reported a position in Boston Scientific in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's Boston Scientific position peaked at $2.82M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.